Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion type Assertion NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_head.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion description "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_provenance.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion evidence source_evidence_literature NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_provenance.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion SIO_000772 21937702 NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_provenance.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion wasDerivedFrom befree-20140225 NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_provenance.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion wasGeneratedBy ECO_0000203 NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_provenance.